Global Ambulatory Surgical Centers Market is Projected to Boost at a Moderate Growth Rate of ~6% by 2030 | DelveInsight

The significant growth in the ambulatory surgical centers market can be credited to several factors highlighting the rising need for multispecialty outpatient surgical facilities. A primary driver behind this upward trend is the growing favoritism towards outpatient surgical centers over traditional hospitals. The inherent benefit of reduced costs associated with outpatient centers compared to hospitals has become a crucial factor impacting patient decisions. This affordability, along with favorable reimbursement conditions, is anticipated to greatly impact the expanding ambulatory surgical centers market.

LAS VEGAS, May 23, 2024 /PRNewswire/ -- DelveInsight's Ambulatory Surgical Centers Market Insights report provides the current and forecast market analysis, individual leading ambulatory surgical centers companies' market shares, challenges, ambulatory surgical centers market drivers, barriers, trends, and key market ambulatory surgical centers companies in the market.

Key Takeaways from the Ambulatory Surgical Centers Market Report

• As per DelveInsight estimates, North America is anticipated to dominate the global ambulatory surgical centers market during the forecast period. 
• Notable ambulatory surgical centers companies such as AMSURG, Surgical Care Affiliates, HCA Healthcare, Tenet Healthcare, Surgery Partners, Cerner Corporation, United Surgical Partners International, Hunterdon Healthcare, Surg Center Gilbert, Beaumont Health, Ambulatory Surgical Centers of America, Center for Health Ambulatory Surgery Centers, TeamHealth, Pediatrix Medical Group, Quoram Health Corporation, and several others, are currently operating in the ambulatory surgical centers market.
• In January 2021, T.H. Medical announced the plans to acquire up to about 25 to 40 ambulatory surgical centers. The company plans to spend an estimated USD 150 million on the acquisition of these surgery centers.
• In January 2018, Medical Facilities Corporation announced an agreement with NueHealth LLC to form a joint venture and acquire seven ambulatory surgical centers from Meridian Surgical Partners of Brentwood.

To read more about the latest highlights related to the ambulatory surgical centers market, get a snapshot of the key highlights entailed in the Global Ambulatory Surgical Centers Market Report

Ambulatory Surgical Centers Overview

Ambulatory Surgical Centers (ASCs) represent a pivotal evolution in healthcare delivery, providing specialized surgical procedures in an outpatient setting. These centers are designed to offer patients a more convenient, cost-effective, and efficient alternative to traditional hospital-based surgeries. Equipped with state-of-the-art technology and staffed by skilled medical professionals, ASCs cater to a wide range of surgical needs, spanning from minor procedures to more complex interventions. Their streamlined operations often translate to shorter wait times, reduced overheads, and a focused approach to patient care, fostering a personalized experience that prioritizes both comfort and safety.

With their emphasis on same-day procedures and swift recovery, Ambulatory Surgical Centers have significantly transformed the landscape of healthcare. Their ability to perform surgeries outside of the hospital environment not only alleviates strain on inpatient facilities but also minimizes the risks associated with prolonged hospital stays, such as infections and patient discomfort. Furthermore, ASCs play a crucial role in enhancing accessibility to surgical care, particularly for individuals requiring elective surgeries or routine procedures. By combining efficiency with excellence in medical care, Ambulatory Surgical Centers continue to emerge as indispensable pillars of modern healthcare delivery, shaping a paradigm where convenience and quality converge for the benefit of patients and healthcare providers alike.

Ambulatory Surgical Centers Market Insights

In the realm of global ambulatory surgical centers, North America maintained its leading position in 2023 and is forecasted to do so from 2024 to 2030. Several factors contribute to this expected dominance, including the increasing preference for ambulatory surgical centers among physicians and patients in the region.

The growing demand for these centers is fueled by factors like a rising number of patients with chronic diseases such as cardiovascular and urological conditions. Additionally, the increasing elderly population in North America, who are more prone to cardiovascular, neurological, and urological disorders, is another significant factor driving the need for ambulatory surgical centers. As per the U.S. Census Bureau in 2021, there were over 54 million adults aged 65 and older in the United States, with projections indicating a rise to 85.7 million by 2050.

Furthermore, the region benefits from a growing awareness of minimally invasive surgical procedures and favorable reimbursement policies for ambulatory surgical centers. The rising demand for advanced imaging systems within these centers also contributes to market growth. Notably, governmental initiatives, along with significant investments from various organizations and key industry players, aimed at improving healthcare infrastructure in North America, are expected to significantly boost the market growth of ambulatory surgical centers.

Therefore, the combination of these factors creates a favorable growth environment for North America in the ambulatory surgical centers market. The region stands as a pivotal player in advancing healthcare solutions, driven by the collaborative efforts of stakeholders to address the evolving needs of the population and enhance overall health outcomes.

To know more about why North America is leading the market growth in the ambulatory surgical centers market, get a snapshot of the Ambulatory Surgical Centers Market Outlook 

Ambulatory Surgical Centers Market Dynamics

The ambulatory surgical centers market has witnessed significant growth in recent years, driven by several key dynamics. One prominent factor is the increasing demand for cost-effective healthcare solutions, coupled with advancements in medical technology. Ambulatory surgical centers offer a convenient and efficient alternative to traditional hospital-based surgery, providing patients with high-quality care in a more comfortable setting. This shift towards outpatient procedures has been further accelerated by changes in reimbursement policies, which incentivize healthcare providers to perform surgeries in ambulatory surgical centers rather than hospitals.

Moreover, the rising prevalence of chronic diseases and the aging population have contributed to the expansion of the ambulatory surgical centers market. As the demand for surgical procedures continues to grow, ambulatory surgical centers play a vital role in meeting this demand by offering specialized services and shorter wait times. Additionally, ambulatory surgical centers such as minimally invasive techniques have enabled a wider range of procedures to be performed in ambulatory surgical centers, further driving ambulatory surgical centers' market growth.

However, the ambulatory surgical centers market also faces challenges such as regulatory compliance, reimbursement issues, and competition from other healthcare providers. Regulatory requirements vary across regions, and ambulatory surgical centers must adhere to strict standards to ensure patient safety and quality of care. Furthermore, reimbursement policies can impact the financial viability of ambulatory surgical centers, and changes in reimbursement rates or regulations can have significant implications for their operations. Despite these challenges, the ambulatory surgical centers market is expected to continue expanding as healthcare delivery models evolve, and ambulatory surgical centers play an increasingly important role in delivering efficient and accessible surgical care.

Get a sneak peek at the ambulatory surgical centers market dynamics @ Ambulatory Surgical Centers Market Dynamics Analysis

Ambulatory Surgical Centers Market Assessment

• Ambulatory Surgical Centers Market Segmentation
• Ambulatory Surgical Centers Market Segmentation By Type: Hospital-Affiliated Ambulatory Surgical Centers (Single-Specialty Centers And Multi-Specialty Centers), and Freestanding Ambulatory Surgical Centers (Single-Specialty Centers and Multi-Specialty Centers)
• Ambulatory Surgical Centers Market Segmentation By Application: Gastroenterology, Ophthalmology, Orthopedics, Pain/Neurology, Urology, Dermatology
• Ambulatory Surgical Centers Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech key players in the ambulatory surgical centers market are set to emerge as the trendsetter explore @ Ambulatory Surgical Centers Companies 

Table of Contents 

Interested in knowing the ambulatory surgical centers market by 2030? Click to get a snapshot of the Ambulatory Surgical Centers Market Trends

Related Reports

Irritable Bowel Syndrome Market

Irritable Bowel Syndrome Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key irritable bowel syndrome companies, including Arena Pharmaceuticals, 4D Pharma, NGM Biopharmaceuticals, OrphoMed, Boston Pharmaceuticals, RedHill Biopharma Limited, Takeda, Cosmo Technologies, CinRx Pharma, Rottapharm, Synthetic Biologics, Biomica, Metacrine, MGC Pharma, Napo Pharmaceuticals, Novome Biotechnologies, Renexxion, Sentia Medical Sciences, Serentrix LLC, Vitality Biopharma, among others.

Ulcerative Colitis Market

Ulcerative Colitis Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key Ulcerative Colitis companies, including Eli Lilly and Company, Lipid Therapeutics, Hoffmann-La Roche, Arena Pharmaceuticals, InDex Pharmaceuticals, EA Pharma, Theravance Biopharma, Boehringer Ingelheim, Janssen Research & Development, Lycera, LG Chem, Iltoo Pharma, Immunic, Hutchison Medipharma, Tianjin Hemay Pharmaceutical, Celgene, among others.

Crohn's Disease Pipeline

Crohn's Disease Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key Crohn's disease companies, including Janssen, RedHill Biopharma, Amgen, Pfizer, Prometheus Biosciences, AgomAb Therapeutics, Hoffmann-La Roche, Gilead Sciences, Eli Lilly and Company, Celgene, AstraZeneca, Mesoblast, Alfasigma, Tiziana Life Sciences, Abivax, Arena Pharmaceuticals, Cytocom, HAV Vaccines Ltd, Enzo Biochem Inc., Stero Biotechs, Reistone Biopharma Company Limited, Qu Biologics, Pfizer, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceuticals, Soligenix, Immunic, Pfizer, Atlantic Healthcare, 4D Pharma, Landos Biopharma, Janssen, Roche, Eisai, Bristol-Myers Squibb, Iltoo Pharma, Suzhou Connect Biopharmaceuticals, Theravance Biopharma, TaiwanJ Pharmaceuticals, Celularity, Cerecor, GlaxoSmithKline, KangStem Biotech, Immunic, Alpha Cancer Technologies, Koutif Therapeutics, Tract Therapeutics, Trio medicines, ChemoCentryx, Algernon Pharmaceuticals, Neuclone, JHL Biotech, Innovative Pharmacological Research (IPHAR) Co Ltd, Innovation Pharmaceuticals, Exeliom Biosciences SAS, AbbVie, Finch Therapeutics, Akeso Biopharma, Draconis Pharma, MakScientific, Engitix, Origo Biopharma, Navidea Biopharmaceuticals, Orchard Therapeutics, Xbrane, Thetis Pharmaceuticals, Temisis Therapeutics, Synedgen, Synlogic, Morphic Therapeutic, Metacrine, Curacle, Commence Bio Inc, Cloud Pharmaceuticals, Chong Kun Dang Pharmaceutical Corp, Avobis Bio LLC, Avexegen Therapeutics, Assembly Biosciences, Aibios Co Ltd, Aclaris Therapeutics, Athos Therapeutics, Denali Therapeutics, Educell doo,  among others.

Irritable Bowel Syndrome Pipeline

Irritable Bowel Syndrome Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key irritable bowel syndrome companies, including Arena Pharmaceuticals, 4D Pharma, OrphoMed, Boston Pharmaceuticals, RedHill Biopharma Limited, Takeda, Cosmo Technologies, CinRx Pharma, Rottapharm, Synthetic Biologics, Biomica, Metacrine, MGC Pharma, Napo Pharmaceuticals, Novome Biotechnologies, Renexxion, Sentia Medical Sciences, Serentrix LLC, Vitality Biopharma, among others.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. 

Contact Us
Shruti Thakur  
info@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices 

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg